LifeStance Health Group, Inc. (LFST) Financial Statements
Industry: Health Services (Services)
In fiscal 2025, LifeStance Health reported revenue of $1.42B, up 13.9% from $1.25B the year before. Net income was $9.7M (a 0.7% net margin), or $0.02 per diluted share. Operating margin was 1.7%. Operating activities generated $146.2M of cash, leaving $110.0M of free cash flow. At fiscal year end, LifeStance Health held $2.20B in total assets against $682.9M in total liabilities, including $248.6M of cash and equivalents.
Open the full interactive LifeStance Health financials → Quarterly statements, key ratios, valuation history and price charts.
LifeStance Health Key Stats
| Share Price | $12.32 |
|---|---|
| Market Cap | $4.77B |
| P/E Ratio | 498.7 |
| Revenue YoY Growth | +13.9% |
| 52-Week Range | $4.81 – $13.38 |
| Shares Outstanding | 383.5 million (basic, 2026 Q2) |
LifeStance Health Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $667.5M | $859.5M | $1.06B | $1.25B | $1.42B |
| Operating Income | -$286.4M | -$210.2M | -$189.1M | -$31.6M | $24.1M |
| Pre-Tax Income | -$333.1M | -$232.7M | -$206.6M | -$57.6M | $12.4M |
| Income Tax | -$25.9M | -$17.2M | -$20.3M | -$170,000 | $2.7M |
| Net Income | -$307.2M | -$215.6M | -$186.3M | -$57.4M | $9.7M |
| Diluted EPS | -$0.94 | — | -$0.51 | -$0.15 | $0.02 |
LifeStance Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $363.8M | $382.2M | $403.5M | $435.4M |
| Net Income | $1.1M | $11.7M | $14.2M | $23.6M |
| Diluted EPS | $0.00 | $0.03 | $0.04 | $0.06 |
LifeStance Health Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $148.0M | $108.6M | $78.8M | $154.6M | $248.6M |
| Current Assets | $266.5M | $233.2M | $225.7M | $312.5M | $416.2M |
| Total Assets | $1.93B | $2.17B | $2.11B | $2.12B | $2.20B |
| Current Liabilities | $116.8M | $176.0M | $202.9M | $228.9M | $252.0M |
| Total Long-Term Debt | $158.7M | $227.4M | $283.2M | $287.0M | $280.4M |
| Total Liabilities | $382.1M | $655.1M | $681.0M | $672.0M | $682.9M |
| Shareholders' Equity | $1.55B | $1.52B | $1.43B | $1.45B | $1.52B |
LifeStance Health Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | $9.4M | $52.8M | -$16.9M | $107.3M | $146.2M |
| Cash From Investing | -$194.1M | -$139.5M | -$60.3M | -$21.6M | -$36.1M |
| Cash From Financing | $313.9M | $47.3M | $47.4M | -$9.9M | -$16.0M |
| Free Cash Flow | -$85.1M | -$26.5M | -$57.4M | $85.7M | $110.0M |
Figures from LifeStance Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full LifeStance Health financials page for every line item.
LifeStance Health Company Profile
| Ticker | LFST |
|---|---|
| Exchange | Nasdaq |
| Industry | Health Services (Services) |
| Headquarters | Scottsdale, Arizona |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001845257 |
Frequently Asked Questions
What was LifeStance Health's revenue in fiscal 2025?
LifeStance Health (LFST) reported revenue of $1.42B for fiscal 2025.
What is LifeStance Health's annual revenue history?
LifeStance Health's annual revenue by fiscal year: 2021: $667.5M; 2022: $859.5M; 2023: $1.06B; 2024: $1.25B; 2025: $1.42B.
What was LifeStance Health's net income in fiscal 2025?
LifeStance Health reported net income of $9.7M for fiscal 2025.
What was LifeStance Health's earnings per share (EPS) in fiscal 2025?
LifeStance Health's diluted EPS was $0.02 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did LifeStance Health generate in fiscal 2025?
LifeStance Health generated $110.0M of free cash flow in fiscal 2025.
What was LifeStance Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), LifeStance Health reported revenue of $435.4M.
How much debt does LifeStance Health have?
LifeStance Health reported $280.4M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of LifeStance Health are outstanding?
LifeStance Health reported a weighted average of 383.5 million basic shares outstanding in 2026 Q2.
What is LifeStance Health's market cap?
Based on its latest closing price, LifeStance Health (LFST) has a market capitalization of about $4.77B.
When does LifeStance Health's fiscal year end?
LifeStance Health's fiscal year end, as registered with the SEC, is December 31.
Where is LifeStance Health headquartered?
LifeStance Health lists its business address in Scottsdale, Arizona in its SEC filings.